Background:
Structural and socio-behavioral barriers to clinic access for continuum of HIV care are major hurdles to medication adherence in areas of lower socioeconomic status. An important indicator of well-being for persons with HIV (PWH) is sustained engagement in care to support viral suppression (VS). Remote VS testing may be supported by self-collected blood in microcollection tubes (MCT), which has benefits over dried blood spots (DBS).
Methods:
We developed a kit with instructions and procedure for remote VS testing using fingerstick blood in EDTA-preservative MCT (Microtainer®) and ambient temperature shipping with temperature monitoring. Separated plasma was used for semi-quantitative RNA testing in a 1:7 dilution protocol that, compared to DBS testing, allows for greater sensitivity (LOQ 210 cp/mL, 99% quantified at 350 cp/mL), requires less sample manipulation, and alleviates DNA contamination. MCTs from 90 participants from various HIV study cohorts willing to self-collect and mail specimens were assessed for allowable shipping time (≤4 days), transit temperature (≤35oC) and plasma volume (≥100 µL). Samples that met the criteria were HIV-1 RNA tested. For 28 participants, a same-day venipuncture sample was obtained for comparison to traditional viral load (VL).
Results:
Of the 90 mailed MCTs, 12 (13%) were rejected on receipt: eight were below volume, three exceeded the temperature limit and one exceeded the shipping period. Four of six participants who obtained another self-collect kit after an unsuccessful fingerstick collection were able to obtain and mail an MCT sample. In total, 81% of persons who attempted self-collection provided a suitable specimen. Seventy-two persons documented to be on PrEP or who were virally suppressed had no viral target detected in the self-collected samples. The six individuals with a quantitated venipuncture VL also had RNA quantitated in MCT (VL range 273 -11,918 cp/mL). Results from the MCT were within 0.31 log10 cp/mL of the VL provided by venipuncture. Hemolyzed specimens were included as hemolysis did not affect test results.
Conclusions:
Untrained individuals were able self-collect and ship sufficient blood volume to support remote viral suppression testing. Gained experience with MCT collection would further increase the high proportion of usable samples. Offering remote VS testing to persons willing to self-collect could overcome recognized barriers to clinic access, support HIV telemedicine, and empower patients to remain in care.